Jpmorgan Chase & CO Apyx Medical Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Apyx Medical Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 60 shares of APYX stock, worth $97. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 65
7.69%
Holding current value
$97
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding APYX
# of Institutions
50Shares Held
17.4MCall Options Held
60.3KPut Options Held
1K-
Archon Capital Management LLC Seattle, WA3.3MShares$5.34 Million5.28% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.26MShares$5.28 Million0.2% of portfolio
-
Royce & Associates LP2.53MShares$4.09 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$2.39 Million0.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT946KShares$1.53 Million100.0% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $56M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...